Novel Presentation to a Rare Disease: Refractory Seizures Caused by Rosai–Dorfman Disease

Rosai–Dorfman disease (RDD) is a non-Langerhans lymphoproliferative disorder that is defined by sinus histiocytosis with massive lymphadenopathy. It can present with a wide spectrum of clinical presentations depending on the organ systems affected. Definitive diagnosis of RDD can be established only by tissue biopsy. Surgical excision is the definitive treatment of localized RDD. We present a case of uncontrolled seizures caused by RDD. Despite surgical excision and multiple antiepileptic agents, the seizure disorder remained uncontrolled. Subsequently, the refractory seizures responded to systemic chemotherapy with rituximab, which has not yet been approved for the treatment of RDD.

Authors

Institutions

Publication Details

Journal
Annals of Internal Medicine Clinical Cases
Published
2024-12-01
DOI
https://doi.org/10.7326/aimcc.2024.0356
Citations
1
Primary Topic
Histiocytic Disorders and Treatments
Type
article
Field-Weighted Citation Impact
0.33
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Novel Presentation to a Rare Disease: Refractory Seizures Caused by Rosai–Dorfman Disease

Amro Ilaiwy, Myint B Thu, Sein Win, Shoon L. Oo
1 citations
Annals of Internal Medicine Clinical Cases
Histiocytic Disorders and Treatments
0.33
article

Novel Presentation to a Rare Disease: Refractory Seizures Caused by Rosai–Dorfman Disease

Amro Ilaiwy, Myint B Thu, Sein Win, Shoon L. Oo
article en
1 citations

Abstract

Rosai–Dorfman disease (RDD) is a non-Langerhans lymphoproliferative disorder that is defined by sinus histiocytosis with massive lymphadenopathy. It can present with a wide spectrum of clinical presentations depending on the organ systems affected. Definitive diagnosis of RDD can be established only by tissue biopsy. Surgical excision is the definitive treatment of localized RDD. We present a case of uncontrolled seizures caused by RDD. Despite surgical excision and multiple antiepileptic agents, the seizure disorder remained uncontrolled. Subsequently, the refractory seizures responded to systemic chemotherapy with rituximab, which has not yet been approved for the treatment of RDD.

Annals of Internal Medicine Clinical CasesVol. 3(12)
Harlem Hospital Center (US), Cape Fear Valley Health System (US)
Openalex Percentile: Top 35%
Histiocytic Disorders and Treatments
0.33
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Novel Presentation to a Rare Disease: Refractory Seizures Caused by Rosai–Dorfman Disease — Amro Ilaiwy, Myint B Thu, et al. · Annals of Internal Medicine Clinical Cases (2024) | TGRS Research Map | TGRS